Multi-Center, Double-Blind, Placebo-Controlled, Monotherapy Study of Neptune Krill Oil (NKO™) in Early Stage Alzheimer's Disease
The purpose of this study is to evaluate the efficacy of NKO™ softgels in reducing decline of global cognitive function as measured by the Neuropsychological Test Battery (NTB), in patients diagnosed with early stage Alzheimer's disease when compared to fish oil and a placebo after 24 weeks of treatment.
100 Clinical Results associated with NeuroBioPharm, Inc.
0 Patents (Medical) associated with NeuroBioPharm, Inc.
100 Deals associated with NeuroBioPharm, Inc.
100 Translational Medicine associated with NeuroBioPharm, Inc.